Abnormal calcium homeostasis in heart failure with preserved ejection fraction is related to both reduced contractile

Ismail Adeniran1, David H MacIver2, Jules C Hancox3

  • 1Biological Physics Group, School of Physics and Astronomy, The University of Manchester Manchester, UK.

Insights

This study models heart failure with preserved ejection fraction (HFpEF), revealing how cellular changes impact heart function. Simulations show HFpEF impairs calcium handling, affecting heart muscle contraction and relaxation.

Area of Science:

  • Cardiology
  • Biophysics
  • Computational Biology

Background:

  • Heart failure with preserved ejection fraction (HFpEF) comprises 50% of heart failure cases.
  • HFpEF is characterized by impaired left ventricular relaxation and increased stiffness.
  • Known associations include abnormal calcium handling, ion channel remodeling, and concentric left ventricle hypertrophy (LVH).

Purpose of the Study:

  • To investigate the electro-mechanical effects of HFpEF-induced cellular changes.
  • To develop multiscale computational models of the human left ventricle incorporating HFpEF characteristics.
  • To understand the cellular mechanisms underlying impaired cardiac electromechanical function in HFpEF.

Main Methods:

  • Developed multiscale computational models of the human left ventricle (single cell to 3D organ).
  • Incorporated HFpEF-specific alterations in calcium handling, ion channel function, and LVH.
  • Simulated ventricular cell and organ-level electro-mechanical dynamics under varying conditions.

Main Results:

  • At the cellular level, HFpEF reduced systolic calcium, decreasing contractile force, and elevated diastolic calcium, causing abnormal residual diastolic force.
  • These cellular electro-mechanical abnormalities were exacerbated by increased heart rate.
  • At the 3D organ level, concentric LVH maintained left ventricular ejection fraction, despite cellular dysfunction.

Conclusions:

  • Computational models successfully replicated observed HFpEF clinical features.
  • Findings provide insights into the cellular basis of impaired electromechanical function in HFpEF.
  • The study highlights the complex interplay between cellular changes and organ-level function in HFpEF.

Related Concept Videos

Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
1.5K
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
4.8K
Imbalances in Cardiac Output01:26

Imbalances in Cardiac Output

The heart's primary function is to pump blood throughout the body, maintaining a balance between blood sent out (cardiac output) and blood returning (venous return). If this balance is disrupted, it can result in congestive heart failure (CHF), a severe condition where the heart becomes an inefficient pump, leading to inadequate blood circulation.
CHF can occur due to the failure of either side of the heart. Left-side failure leads to pulmonary congestion—the right side continues to send...
3.5K
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...
1.3K
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
803
Pathophysiology of Cardiac Performance01:29

Pathophysiology of Cardiac Performance

Typical heart performance is influenced by heart rate, rhythm, myocardial contraction, and metabolism or blood flow. The cardiac muscle exhibits distinct electrophysiological features, including pacemaker activity and calcium channel control, which play a vital role in the heart's response to various drugs. The autonomic nervous system, comprising the sympathetic and parasympathetic branches, regulates heart rate. Sympathetic activation increases heart rate, while parasympathetic activation...
2.1K